Bank Of Montreal Stoke Therapeutics, Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$7.07 - $15.69 $2.41 Million - $5.36 Million	-341,400 Reduced 44.38%	427,888 $3.95 Million
Q3 2022 Nov 10, 2022	SELL	$12.56 - $22.53 $3.06 Million - $5.49 Million	-243,783 Reduced 24.06%	769,288 $11.4 Million
Q2 2022 Aug 11, 2022	BUY	$10.36 - $23.93 $10.5 Million - $24.2 Million	1,013,071 New	1,013,071 $13.8 Million

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $367M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.